Product Name | Lusutrombopag |
---|---|
CAS | 1110766-97-6 |
Formula | C29H32Cl2N2O5S |
MW | 591.55 |
MDL | MFCD28502075 |
Appearance | White to off-white powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
5 mg | 3-5days | $400.00 | Visible after login | |
10 mg | 3-5days | $600.00 | Visible after login |
Product Name | Lusutrombopag |
---|---|
CAS | 1110766-97-6 |
Formula | C29H32Cl2N2O5S |
MW | 591.55 |
MDL | MFCD28502075 |
Appearance | White to off-white powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Lusutrombopag (formerly known as S888711; S-888711;trade name:Mulpleta) is a novel orally bioavailable, small molecule agonist of thrombopoietin (TPO) receptor.
Lusutrombopag: First Global Approval.
PMID: 26666417 DOI: 10.1007/s40265-015-0525-4